Later, after combined treatment with an IL-6 antagonist, the objective data indicated a satisfactory curative effect, with decreases in various inflammatory indexes and control of her clinical symptoms, suggesting that hormonotherapy and cytokine/chemokine therapy may be potential novel therapeutic strategies for patients with ECD without gene mutations. Here, IL6 is linked to familial atrioventricular septal defect.